Back to Clinical Trials Overview

Your search for "Depression" returned 19 results:


Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression
Principal Investigator(s): Dan Iosifescu

Double-Blind, Proof-of-Concept (POC) Trial of Low Field Magnetic Stimulation (LFMS) Augmentation of Antidepressant Therapy in Treatment-Resistant Depression (TRD)
Principal Investigator(s): Dan Iosifescu

The Neuroimmunology of Anhedonia
Principal Investigator(s): Gabbay, Vilma

Ketamine Plus Lithium as a Novel Pharmacotherapeutic Strategy in Treatment Resistant Depression
Principal Investigator(s): James Murrough, MD

Cognitive Training for Mood and Anxiety Disorders
Principal Investigator(s): Brian Iacoviello

Cognitive Training in Depression
Principal Investigator(s): Brian Iacoviello

Specificity and Validity of Oxidative Stress Model of Chronic Fatigue Syndrome
Principal Investigator(s): Dan Iosifescu

A Prospective, Double Blind, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the H1-Coil deep Transcranial Magnetic Stimulation (TMS) in conjunction with mood stabilizers in Subjects with Bipolar Depression
Principal Investigator(s): Dan Iosifescu

A Double-Blind, Placebo-Controlled, Multicenter Study of Sirukumab as Adjunctive Treatment to a MonoAminergic Antidepressant in Adults with Major Depressive Disorder
Principal Investigator(s): James Murrough

A Phase 3 Multicenter Study of the Long-term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Principal Investigator(s): Dan Iosifescu

Neuroinflammation and Positive Valence System Deficits in Adolescents
Principal Investigator(s): Gabbay, Vilma

A Clinical Pilot Study Examining Bilateral Inhibition of the Lateral Habenula as a Target for Deep Brain Stimulation in Intractable Depression
Principal Investigator(s): Wayne Goodman

Dopamine and Motivation in Depression
Principal Investigator(s): Dan Iosifescu

A Proof-Of-Concept Clinical Trial of a Novel KCNQ Potentiator in Major Depressive Disorder
Principal Investigator(s): James Murrough

Double-blind, Randomized Study of Extended-release Quetiapine Fumarate (Seroquel XR) in the Treatment of Patients with Comorbid Depression and Anxiety Disorder
Principal Investigator(s): Hirschowitz, Jack

An fMRI Study of Ketamine in Treatment-Resistant Depression
Principal Investigator(s): James Murrough

Phase 2A Study to Evaluate the Kappa Opioid Receptor as a Target for the Treatment of Mood and Anxiety Spectrum Disorders By Evaluating Whether LY2456302 Engages Reward-related Neural Circuitry
Principal Investigator(s): Wayne Goodman

Ketamine as a Rapid Treatment for Post-Traumatic Stress
Principal Investigator(s): Feder, Adriana

Screening for Depression in Patients with Multiple Sclerosis
Principal Investigator(s): Ben-Zacharia, Aliza